Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Ciclosporin
Verkazia
Routinely available
SMC (SMC2111)
12/11/2025
Indication
Treatment of severe vernal keratoconjunctivitis (VKC) in children from 4 years of age and adolescents (until the age of 18)
Therapeutic Area
Eye
Status Description
Routinely available in line with national guidance
Formulation
1mg/mL (0.1%) eye drops emulsion